407 related articles for article (PubMed ID: 34880424)
21. MixClone: a mixture model for inferring tumor subclonal populations.
Li Y; Xie X
BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S1. PubMed ID: 25707430
[TBL] [Abstract][Full Text] [Related]
22. Advances in understanding cancer genomes through second-generation sequencing.
Meyerson M; Gabriel S; Getz G
Nat Rev Genet; 2010 Oct; 11(10):685-96. PubMed ID: 20847746
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive characterization of complex structural variations in cancer by directly comparing genome sequence reads.
Moncunill V; Gonzalez S; Beà S; Andrieux LO; Salaverria I; Royo C; Martinez L; Puiggròs M; Segura-Wang M; Stütz AM; Navarro A; Royo R; Gelpí JL; Gut IG; López-Otín C; Orozco M; Korbel JO; Campo E; Puente XS; Torrents D
Nat Biotechnol; 2014 Nov; 32(11):1106-12. PubMed ID: 25344728
[TBL] [Abstract][Full Text] [Related]
24. Detecting Somatic Mutations in Normal Cells.
Dou Y; Gold HD; Luquette LJ; Park PJ
Trends Genet; 2018 Jul; 34(7):545-557. PubMed ID: 29731376
[TBL] [Abstract][Full Text] [Related]
25. DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly.
Scheinin I; Sie D; Bengtsson H; van de Wiel MA; Olshen AB; van Thuijl HF; van Essen HF; Eijk PP; Rustenburg F; Meijer GA; Reijneveld JC; Wesseling P; Pinkel D; Albertson DG; Ylstra B
Genome Res; 2014 Dec; 24(12):2022-32. PubMed ID: 25236618
[TBL] [Abstract][Full Text] [Related]
26. Estimation of rearrangement phylogeny for cancer genomes.
Greenman CD; Pleasance ED; Newman S; Yang F; Fu B; Nik-Zainal S; Jones D; Lau KW; Carter N; Edwards PA; Futreal PA; Stratton MR; Campbell PJ
Genome Res; 2012 Feb; 22(2):346-61. PubMed ID: 21994251
[TBL] [Abstract][Full Text] [Related]
27. Computational approaches for discovery of mutational signatures in cancer.
Baez-Ortega A; Gori K
Brief Bioinform; 2019 Jan; 20(1):77-88. PubMed ID: 28968631
[TBL] [Abstract][Full Text] [Related]
28. seqCNA: an R package for DNA copy number analysis in cancer using high-throughput sequencing.
Mosen-Ansorena D; Telleria N; Veganzones S; De la Orden V; Maestro ML; Aransay AM
BMC Genomics; 2014 Mar; 15(1):178. PubMed ID: 24597965
[TBL] [Abstract][Full Text] [Related]
29. Toward Recovering Allele-specific Cancer Genome Graphs.
Rajaraman A; Ma J
J Comput Biol; 2018 Jul; 25(7):624-636. PubMed ID: 29658776
[TBL] [Abstract][Full Text] [Related]
30. SynthEx: a synthetic-normal-based DNA sequencing tool for copy number alteration detection and tumor heterogeneity profiling.
Silva GO; Siegel MB; Mose LE; Parker JS; Sun W; Perou CM; Chen M
Genome Biol; 2017 Apr; 18(1):66. PubMed ID: 28390427
[TBL] [Abstract][Full Text] [Related]
31. Control-FREEC viewer: a tool for the visualization and exploration of copy number variation data.
Crippa V; Fina E; Ramazzotti D; Piazza R
BMC Bioinformatics; 2024 Feb; 25(1):72. PubMed ID: 38355453
[TBL] [Abstract][Full Text] [Related]
32. Targeted deep resequencing of the human cancer genome using next-generation technologies.
Myllykangas S; Ji HP
Biotechnol Genet Eng Rev; 2010; 27():135-58. PubMed ID: 21415896
[TBL] [Abstract][Full Text] [Related]
33. SAAS-CNV: A Joint Segmentation Approach on Aggregated and Allele Specific Signals for the Identification of Somatic Copy Number Alterations with Next-Generation Sequencing Data.
Zhang Z; Hao K
PLoS Comput Biol; 2015 Nov; 11(11):e1004618. PubMed ID: 26583378
[TBL] [Abstract][Full Text] [Related]
34. An evaluation of copy number variation detection tools for cancer using whole exome sequencing data.
Zare F; Dow M; Monteleone N; Hosny A; Nabavi S
BMC Bioinformatics; 2017 May; 18(1):286. PubMed ID: 28569140
[TBL] [Abstract][Full Text] [Related]
35. Whole genome sequencing analysis for cancer genomics and precision medicine.
Nakagawa H; Fujita M
Cancer Sci; 2018 Mar; 109(3):513-522. PubMed ID: 29345757
[TBL] [Abstract][Full Text] [Related]
36. Characterizing and interpreting genetic variation from personal genome sequencing.
Johansson AC; Feuk L
Methods Mol Biol; 2012; 838():343-67. PubMed ID: 22228021
[TBL] [Abstract][Full Text] [Related]
37. Whole Genome Sequencing-Based Discovery of Structural Variants in Glioblastoma.
Wrzeszczynski KO; Felice V; Shah M; Rahman S; Emde AK; Jobanputra V; O Frank M; Darnell RB
Methods Mol Biol; 2018; 1741():1-29. PubMed ID: 29392687
[TBL] [Abstract][Full Text] [Related]
38. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
39. Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines.
Woo XY; Srivastava A; Graber JH; Yadav V; Sarsani VK; Simons A; Beane G; Grubb S; Ananda G; Liu R; Stafford G; Chuang JH; Airhart SD; Karuturi RKM; George J; Bult CJ
BMC Med Genomics; 2019 Jul; 12(1):92. PubMed ID: 31262303
[TBL] [Abstract][Full Text] [Related]
40. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
